Table 2.
Index TEER Procedure Characteristics
| TEER procedure details | Mitral surgery (N=44) | Medical therapy (N=98) | P value |
|---|---|---|---|
| Etiology of MR | |||
| Primary, n (%) | 23 (52.3) | 52 (53.1) | 0.93 |
| Secondary, n (%) | 6 (13.6) | 14 (14.3) | 0.92 |
| Mixed primary/secondary, n (%) | 15 (34.1) | 32 (32.6) | 0.87 |
| Number of TEER devices | |||
| 1 clip implanted, n (%) | 26 (59.2) | 49 (50.0) | 0.32 |
| 2 clips implanted, n (%) | 18 (40.8) | 49 (50.0) | 0.32 |
| Post‐TEER deployment | |||
| ≤Moderate MR, n (%) | 36 (81.8) | 86 (87.8) | 0.35 |
| Mitral gradient, mm Hg | 4.6±2.2 | 4.0±1.8 | 0.13 |
| Tricuspid regurgitation | |||
| Moderate, n (%) | 10 (22.7) | 23 (23.4) | 0.92 |
| Severe, n (%) | 6 (13.6) | 20 (20.4) | 0.33 |
MR indicates mitral regurgitation; and TEER, transcatheter edge‐to‐edge repair.